MM

Michael John Munchhof

Pfizer: 31 patents #62 of 5,153Top 2%
EP Epizyme: 26 patents #9 of 65Top 15%
EL Eli Lilly: 4 patents #824 of 2,858Top 30%
Overall (All Time): #42,937 of 4,157,543Top 2%
57
Patents All Time

Issued Patents All Time

Showing 25 most recent of 57 patents

Patent #TitleCo-InventorsDate
12116358 Substituted indoles and methods of use thereof John W. Lampe, John Emmerson Campbell, Kenneth W. Duncan, Megan Foley, Darren Harvey +2 more 2024-10-15
11970485 RET kinase inhibitors Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more 2024-04-30
11964968 Compounds useful for inhibiting RET kinase Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Gabrielle R. Kolakowski +4 more 2024-04-23
11697647 RET kinase inhibitors Gabrielle R. Kolakowski, Erin Danielle ANDERSON, Steven W. Andrews, Christopher Pierre Albert Jean Boldron, Kevin Ronald Condroski +9 more 2023-07-11
11613533 Compounds useful for inhibiting RET kinase Erin Danielle ANDERSON, Steven W. Andrews, Kevin Ronald Condroski, Thomas Combs IRVIN, Gabrielle R. Kolakowski +4 more 2023-03-28
10980794 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2021-04-20
10653693 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin, Elayne PENEBRE +1 more 2020-05-19
10577363 Substituted piperidine compounds Lorna Helen Mitchell, Andrew Simon Bell, Richard Chesworth, Megan Foley, Kevin Wayne Kuntz +1 more 2020-03-03
10428029 Isoxazole carboxamide compounds Megan Foley, Kevin Wayne Kuntz, James Edward John Mills, Lorna Helen Mitchell, Darren Harvey 2019-10-01
10391089 PRMT5 inhibitors and uses therof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2019-08-27
10307413 Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2019-06-04
10266526 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer Megan Foley, Kevin Wayne Kuntz, James Edward John Mills, Lorna Helen Mitchell, Darren Harvey 2019-04-23
10150758 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth 2018-12-11
10118918 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin 2018-11-06
10106510 Substituted isoxazoles for treating cancer Megan Foley, Kevin Wayne Kuntz, Lorna Helen Mitchell 2018-10-23
9908887 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Lei Jin 2018-03-06
9777008 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Lei Jin 2017-10-03
9765068 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2017-09-19
9745291 PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2017-08-29
9732072 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin 2017-08-15
9675614 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2017-06-13
9611257 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth 2017-04-04
9604930 Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Paula Ann Boriack-Sjodin, Lei Jin 2017-03-28
9388173 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth, Lei Jin 2016-07-12
9365555 PRMT5 inhibitors and uses thereof Kenneth W. Duncan, Richard Chesworth 2016-06-14